Staging is based on surgicopathological findings.
Stage 0
Carcinoma in situ (endometrial hyperplasia with cytological atypia)
Stage I
Stage IA: Tumour limited to the endometrium
Stage IB: Invasion of less that half of the myometrium
Stage IC: Invasion equal to or greater than half of the myometrium
Stage II
Stage IIA: Endocervical glandular involvement only
Stage IIB: Cervical stromal invasion
Stage III
Stage IIIA: Tumour invades serosa of the uterus and/or adnexa, and/or
positive peritoneal cytology
Stage IIIB: Vaginal metastases
Stage IIIC: Metastases to pelvic and/or para-aortic lymph nodes
Stage IV
Stage IVA: Tumour invasion of bladder and/or bowel mucosa
Stage IVB: Distant metastases including intra-abdominal and/or
inguinal lymph nodes (disease outside the true pelvis)
Dr Andreas Obermair, MD
Associate
Professor of Gynecology and Obstetrics,
University
of Vienna
Clinical Fellow,
Gynaecologic Oncology,Queensland Centre for
Gynaecological Cancer.
